@covidmecfshelp1 @MoMoPerry @dysclinic Both studies are open-access: https://t.co/EAisEI8rsq and https://t.co/S3ZSrkhmnR should give you all the details.
@sfadigacronica Double blind RCT fails primary endpoint: https://t.co/EAisEI8rsq Long-term follow-up showing 38% remission: https://t.co/S3ZSrkhmnR
Benefit from B-Lymphocyte Depletion Using the Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome. A Double-Blind and Placebo-Controlled Study | PLOS ONE https://t.co/BhMVT3cnLi
@dokhollidays möchte darauf hinweisen, dass ich persönlich es auch zu riskant finde, zu viele negative Fallbeispiele, doch null Evidenz stimmt einfach nicht, gibt eine Studien, ja sehr kleine aber es gibt sie https://t.co/5sIWNJm6DC & eine 2. von Prof.
@dokhollidays @glasspateldruck Die Studien Ergebnisse sind sehr durchwachsen aber der Ansatz ist klar zielführend https://t.co/MEKs1gipa7 https://t.co/vnf2IGmElC https://t.co/P0iNOq5Ehb https://t.co/v2RnrnoPx8
@KristianGunder @KathrineErikse6 @Festlegen @klangeriturkis @Diplodokus1 @ninakanninakan @AnnMauseth @OGadeholt @PerHelgeM @martinfinne @SFlottorp @Ventzakov @SigridSollund @gadeholt Fluge, Ø., Mella, O. et al. Benefit from B-Lymphocyte Depletion Using the
@Prebens @legeforeningen Fluge og Mella var tydeligvis en irritasjon allerede i 2012. Du og dine astroturfere fortsetter å jobbe aktivt mot biomedisinske forskning. Dette er ikke logisk, What’s in it for you?https://t.co/f5fkmCiyne
あれ?リツキシマブが効果あるという論文?? と、よく見たら2011年の古い情報。 https://t.co/Q7lW9CG5EO
How much more scientific proof do we need to effectively treat #ME, #MEAction, https://t.co/FUVwBXf4Yx
@IsabelHardman This would be a good place to start: https://t.co/ZF47VQc0fE Proof of principle & where the roots of the illness to be found
If you haven't already read "Occam's (or OspA's) Razor, I highly suggest you do so, along with the vetted... https://t.co/f7fojkvdlt
@jessicaelgot The real game in town for ME is Rituximab suggesting auto-immune disease https://t.co/TZW7c7XOlF not CBT/GET as Sharpe claims.
@siljeendresen Synd Wyller feilinformerer om blinding av Rituximab-studien. Unnlinding var etter 12 måneder - ikke 3 https://t.co/Dzh8O1YBYj
@KatarinaLien "The patients were blinded for group allocation until the end of follow-up (at least 12 months...)" https://t.co/Dzh8O1YBYj
@Prebens Fluge og Mella gjør rede for resultatene her, i sitt svar til Mats Reimer: http://t.co/I6alEYYH9E @OlavJensenNOR
RT @ValeBodi: @atulbutte @ImmPortDB https://t.co/OOrahZUFMp and http://t.co/RXdoHma3sa and http://t.co/b26DVxXJLi as well as http://t.co/vh…
@atulbutte @ImmPortDB https://t.co/OOrahZUFMp and http://t.co/RXdoHma3sa and http://t.co/b26DVxXJLi as well as http://t.co/vhvhfwNnce @OMF
@Macanders 2011 RCT Phase II: http://t.co/r4RYFgm0Au 2015 Phase II Open-Label: http://t.co/tfNt2luOFR Phase III RCT currently underway.
RT @LetsDoIt4ME: @SlCathy @Macanders @crochetkid75 10/15 (of 30) responded in Phase II double-blind placebo-controlled study pub. 2011 http…
RT @LetsDoIt4ME: @SlCathy @Macanders @crochetkid75 10/15 (of 30) responded in Phase II double-blind placebo-controlled study pub. 2011 http…
@SlCathy @Macanders @crochetkid75 10/15 (of 30) responded in Phase II double-blind placebo-controlled study pub. 2011 http://t.co/hKof6Iv1qi
#rkiErkenntnisstandCFS @rki_de hat die norwegischen Rituximabstudien verpennt! @BMG_Bund http://t.co/xmdm26jNEH http://t.co/5XufCEdyYf
@Mirka777 Ja http://t.co/FMz7mRHwwr Les også kritiske kommentarer http://t.co/De2neL1sa1 @WasimZahid @OlavJensenNOR @MeggeLise
Dr Collins- The Norweigians are ahead on #CFS research! Gallo & Fauci losing out again! http://t.co/RZGineY2X3 #StopP2P4ME @NIHDirector
Dr Fauci-The Norweigians r ahead on #CFS research-mopping up the floor with your propaganda! http://t.co/RZGineY2X3 @NIAIDNews #StopP2P4ME
Dr Fauci-The Norweigians r ahead on #CFS research-mopping up the floor with your propaganda! http://t.co/RZGineY2X3 @NIAIDNews #StopP2P4ME
Dr Collins- The Norweigians are ahead on #CFS research! Gallo & Fauci losing out again! http://t.co/RZGineY2X3 #StopP2P4ME @NIHDirector
Dr Collins- The Norweigians are ahead on #CFS research! Gallo & Fauci losing out again! http://t.co/RZGineY2X3 #StopP2P4ME @NIHDirector
Dr Fauci-The Norweigians r ahead on #CFS research-mopping up the floor with your propaganda! http://t.co/RZGineY2X3 @NIAIDNews #StopP2P4ME
Dr Collins- The Norweigians are ahead on #CFS research! Gallo & Fauci losing out again! http://t.co/RZGineY2X3 #StopP2P4ME @NIHDirector
@IDDocHymes This: http://t.co/GLBjxwcZMt ME/CFS
rituximab: http://t.co/qeB3C12w8i
"@ninasvensson: Don't miss the drug which makes 1/3 of #mecfs patients well: http://t.co/LYwheBliQ8 #dkpol" « interesting
Don't miss the drug which makes 1/3 of #mecfs patients well: http://t.co/xV2JYteVAT #dkpol
Don't miss the drug which makes 1/3 of #mecfs patients well: http://t.co/xV2JYteVAT #dkpol
Benefit from B-Lymphocyte Depletion Using the Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome. http://t.co/vfbmcjDgAJ
Comment on Fluge Ø (2011): Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic http://t.co/LbxjigXGn5
@PerKohler Här är btw bland det mest spännande som har hänt de senaste åren, om du inte har sett det: http://t.co/sceGMXq9OK #SvMECFS #Svmed
@unigolyn This is one of the most interesting studies http://t.co/A7pSdbWUh8
@DondochakkaB Do not think so... This will be a second phasestudy. The pilotstudy: http://t.co/MLCovXVEHU / @TomKindlon
@jenbrea Here's a link to the research article in PLOS ONE regarding Rituximab: http://t.co/nUclxbe2Gy This is a big leap forward!
Fluge and Mella "Although poorly understood, immune system alterations seen in stress-related diseases such as... http://t.co/AsS2Tisa8t
Jonathan Edwards admits he is not aware of all Rituximab scientific evidence in different diseases. #MEcfs #spoonie http://t.co/7p1ls5IIWw
Jonathan Edwards admits he is not aware of all Rituximab scientific evidence in different diseases. #MEcfs #spoonie http://t.co/7p1ls5IIWw
PLOS ONE: Benefit from B-Lymphocyte Depletion Using the Anti-CD20 Antibody Rituximab in Chronic... http://t.co/1b9ijA3B5R
@KRdland beklager, med KTS-1 mener jeg selvsagt http://t.co/yhb0eImKsb @Livelandmark
@WesselyS @Sea1kay For the near future, this looks promising: http://t.co/0JTEAGr4NF, http://t.co/S8Iz6kdGst :)
@MEandYouFund Fluge/Mella paper in PlosOne Oct/2011 - amazing 47,840 views-Quite an achievement for a CFS (ME) study http://t.co/S3TLYrIXVV
@MEandYouFund Fluge/Mella paper in PlosOne Oct/2011 - amazing 47,840 views-Quite an achievement for a CFS (ME) study http://t.co/S3TLYrIXVV
@MEandYouFund Fluge/Mella paper in PlosOne Oct/2011 - amazing 47,840 views-Quite an achievement for a CFS (ME) study http://t.co/S3TLYrIXVV
@MEandYouFund Fluge/Mella paper in PlosOne Oct/2011 - amazing 47,840 views-Quite an achievement for a CFS (ME) study http://t.co/S3TLYrIXVV
@haukeland_no Fluge/Mella paper in PlosOne Oct/2011 - amazing 47,840 views-Quite an achievement for a CFS (ME) study http://t.co/S3TLYrIXVV
@EUROMEALL Fluge/Mella paper in PlosOne Oct/2011 - amazing 47,840 views-Quite an achievement for a CFS (ME) study http://t.co/S3TLYrIXVV
@MEandYouFund Fluge/Mella paper in PlosOne Oct/2011 - amazing 47,840 views-Quite an achievement for a CFS (ME) study http://t.co/S3TLYrIXVV
@davoy Fluge/Mella paper in PlosOne Oct/2011 - amazing 47,840 views-Quite an achievement for a CFS (ME) study http://t.co/S3TLYrIXVV
@MEforeningen Fluge/Mella paper in PlosOne Oct/2011 - amazing 47,840 views-Quite an achievement for a CFS (ME) study http://t.co/S3TLYrIXVV
@PLOSONE Fluge/Mella paper in PlosOne Oct/2011 - amazing 47,840 views-Quite an achievement for a CFS (ME) study http://t.co/S3TLYrIXVV
@PLOSMedicine Fluge/Mella paper in PlosOne Oct/2011 - amazing 47,840 views-Quite an achievement for a CFS (ME) study http://t.co/S3TLYrIXVV
@haukeland_no Fluge/Mella paper in PlosOne Oct/2011 - amazing 47,840 views-Quite an achievement for a CFS (ME) study http://t.co/S3TLYrIXVV
@KavliFoundation Fluge/Mella paper PlosOne Oct/2011 - amazing 47,840 views-Quite an achievement for a CFS (ME) study http://t.co/S3TLYrIXVV
@Helsedir Fluge/Mella paper in PlosOne Oct/2011 - amazing 47,840 views-Quite an achievement for a CFS (ME) study http://t.co/S3TLYrIXVV
@MyalgicEncephal Same patients as in the second phase: http://t.co/wFAuol2izS cc/ @Gooische_Vrouw
@ProfRWinston @ollie72 Have you looked at the science. Rituximab study from norway http://t.co/PmfPoD4z suggest immune system involvement
"Rituximab should not be used to treat CFS/ME outside of clinical studies at present" -Fluge/Mella okt 2011 http://t.co/TGNFbvbH @WasimZahid
@davoy NFR er positive til planlagt prosjekt. OK. Men jeg peker på svakheter i den forrige studien http://t.co/NhhCBcMn
@h_kjernli Svakheter hos Fluge/Mella, se under Comments, særlig matsreimer og jvandermeer http://t.co/NhhCBcMn @davoy @WasimZahid
@h_kjernli Svakheter hos Fluge/Mella, se under Comments, særlig matsreimer og jvandermeer http://t.co/NhhCBcMn @davoy @WasimZahid
@FredrikESP Eller at utenlandske forskere ikke er så imponert over studien, som hadde alvorlige metodeproblemer http://t.co/NhhCBcMn
Hva mener du om denne, http://t.co/cHrfz3mC @henrikvogt? Hva jeg er opptatt av. @FredrikESP @DrBergland @Epidemino @StineCamilla @drskavlan
@aakeeld Sikter til dette: http://t.co/YbjQAYVb @Bettan2 @MariasMetode
@janwly @alanrew @DoctorChristian Moren interesting treatment for ME. http://t.co/PmfPoD4z suggests ME is immune disorder pos autoimmune
@KirstyDuncanMP 258 Days ago Rituximab was shown to benefit #MECFS http://t.co/sIwkB0wc To date no MP has asked for clinical trial. #cdnpoli
@KirstyDuncanMP 257 Days ago Rituximab was shown to benefit #MECFS http://t.co/sIwkB0wc To date no MP has asked for clinical trial. #cdnpoli
RT @RichCarsonsDeal: Rituximab in Chronic Fatigue Syndrome--A Double-Blind and Placebo-Controlled Study. http://t.co/p5WXuhFE
@psyned Rituximab in Chronic Fatigue Syndrome--A Double-Blind and Placebo-Controlled Study. http://t.co/1lYEMhoo
Rituximab in Chronic Fatigue Syndrome--A Double-Blind and Placebo-Controlled Study. http://t.co/1lYEMhoo
@markstrahl http://t.co/sIwkB0wc http://t.co/sg3NcMt1 Potential treatment found for #MECFS. Why no clinical trials? #cndpoli #MECFS #PNP
@ElizabethMay http://t.co/sIwkB0wc http://t.co/sg3NcMt1 Potential treatment found for #MECFS. Why no clinical trials? #cndpoli #MECFS #PNP
@LindaDuncanMP http://t.co/sIwkB0wc http://t.co/sg3NcMt1 Potential treatment found for #MECFS. Why no clinical trials? #cndpoli #MECFS #PNP
@MikeWallaceMP http://t.co/sIwkB0wc http://t.co/sg3NcMt1 Potential treatment found for #MECFS. Why no clinical trials? #cndpoli #MECFS #PNP
@leonaaglukkaq http://t.co/sIwkB0wc http://t.co/sg3NcMt1 Potential treatment found for #MECFS. Why no clinical trials? #cndpoli #MECFS #PNP
@KirstyDuncanMP http://t.co/sIwkB0wc http://t.co/sg3NcMt1 Potential treatment found for #MECFS. Why no clinical trials? #cndpoli #MECFS
Rituximab in Chronic Fatigue Syndrome--A Double-Blind and Placebo-Controlled Study. http://t.co/p5WXuhFE
RT @RichCarsonsDeal: Rituximab in Chronic Fatigue Syndrome--A Double-Blind and Placebo-Controlled Study. http://t.co/p5WXuhFE
Rituximab in Chronic Fatigue Syndrome--A Double-Blind and Placebo-Controlled Study. http://t.co/p5WXuhFE
@evansolomoncbc http://t.co/sIwkB0wc http://t.co/sg3NcMt1 Potential treatment found for #MECFS. Why no clinical trials? #cndpoli #MECFS #PNP
@ElizabethMay http://t.co/sIwkB0wc http://t.co/sg3NcMt1 Potential treatment found for #MECFS. Why no clinical trials? #cndpoli #MECFS #PNP
@bobraeMP http://t.co/sIwkB0wc http://t.co/sg3NcMt1 Potential treatment found for #MECFS. Why no clinical trials? #cndpoli #MECFS #PNP
@Cathy_McLeod http://t.co/sIwkB0wc http://t.co/sg3NcMt1 Potential treatment found for #MECFS. Why no clinical trials? #cndpoli #MECFS #PNP
@evansolomoncbc http://t.co/sIwkB0wc http://t.co/sg3NcMt1 Potential treatment found for #MECFS. Why no clinical trials? #cndpoli #MECFS #PNP
@ColinCarrie http://t.co/sIwkB0wc http://t.co/sg3NcMt1 Potential treatment found for #MECFS. Why no clinical trials? #cndpoli #MECFS #PNP
@GlennThibeault http://t.co/sIwkB0wc http://t.co/sg3NcMt1 Potential treatment found for #MECFS. Why no clinical trials? #cndpoli #MECFS #PNP
@PaulDewar http://t.co/sIwkB0wc http://t.co/sg3NcMt1 Potential treatment found for #MECFS. Why no clinical trials? #cndpoli #MECFS #PNP
@oliviachow http://t.co/sIwkB0wc http://t.co/sg3NcMt1 Potential treatment found for #MECFS. Why no clinical trials? #cndpoli #MECFS #PNP
@LibbyDavies http://t.co/sIwkB0wc http://t.co/sg3NcMt1 Potential treatment found for #MECFS. Why no clinical trials? #cndpoli #MECFS #PNP
A PT member just shared this article with me and wrote: Impressive CFS Study "This one is worth reading... http://t.co/yVL8nVKP
@brucehyer http://t.co/sIwkB0wc 400,000 Canadian #MECFS patients NEED Rituximab Clinical Trials NOW. #cdnpoli #health (We need your help)
@GlennThibeault http://t.co/sIwkB0wc 400,000 Canadian #MECFS patients NEED Rituximab Clinical Trials NOW. #cdnpoli #health (We need help)
@tedhsu http://t.co/sIwkB0wc 400,000 Canadian #MECFS patients NEED Rituximab Clinical Trials NOW. #cdnpoli #health (We need your help)